A phase II trial of neoadjuvant chemoradiotherapy with intensity-modulated radiotherapy combined with gemcitabine and S-1 for borderline-resectable pancreatic cancer with arterial involvement
暂无分享,去创建一个
Y. Nagakawa | K. Kasuya | A. Tsuchida | H. Nakayama | Yatsuka Sahara | Y. Hosokawa | C. Takishita | K. Katsumata | K. Tokuuye | Yousuke Hijikata | T. Nakajima